Index · Artikel · Some tanners return to the booth after skin cancer

Some tanners return to the booth after skin cancer

2013-07-09 4
   
Advertisement
résuméNEW YORK (Reuters Health) - One in seven people goes back to a tanning bed after being diagnosed with skin cancer, according to a new research letter. Indoor tanning is known to increase a person's risk for cancer. "The situation may be analogous to
Advertisement

Some tanners return to the booth after skin cancer


NEW YORK (Reuters Health) - One in seven people goes back to a tanning bed after being diagnosed with skin cancer, according to a new research letter.

Indoor tanning is known to increase a person's risk for cancer.

"The situation may be analogous to that of lung cancer patients who continue to smoke after diagnosis," said lead author Brenda Cartmel, a cancer prevention researcher at the Yale School of Public Health in New Haven, Connecticut.

"Just as tobacco is known to be addictive, our research suggests that some patients may become dependent on tanning, with new intervention approaches needed to change these behaviors," she told Reuters Health.

Most of the 20 million people who use tanning beds in the U.S. each year are young white women. The beds emit up to 15 times the ultraviolet A (UVA) radiation of the sun. That type of radiation damages deep layers of skin.

The new study included people who had been diagnosed with basal cell carcinoma - a slow-growing skin cancer which can be removed but increases the risk for subsequent skin cancers - before age 40.

Basal cell carcinoma is the most common type of cancer in the U.S., and occurs most often among men over the age of 50. But other studies have found an increased number of those cancers among young women in the last 30 years, which inspired the current investigation, Cartmel said.

She and her coauthors surveyed white patients in Connecticut who had participated in a study of basal cell carcinoma one to four years earlier. The researchers included results from the 178 people who had tanned indoors before being diagnosed.

Of them, 26 - about 15 percent - said they had tanned indoors again at least once over the past year, with some visiting the booth up to 20 times, according to findings published in JAMA Dermatology. Those people reported tanning more often before their diagnosis than the rest of the group.

More than half of the still-tanners reported symptoms of dependence, such as feeling guilty about tanning or needing to tan first thing in the morning, compared to 36 percent of those who had quit tanning.

"This is not surprising at all," said Dr. Steven Feldman, a dermatologist at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina.

There's a lot of evidence that UV light exposure can be addictive, he told Reuters Health.

"If you take skin cells in culture and expose them to UV light, they make endorphins, those feel-good molecules," he said.

Like nicotine, Feldman said, tanning has social pressures at work but can also be physically addictive. But unlike cigarette smoke, which has been banned in many public places, indoor tanning only harms the individual who gets in the booth. There's no such thing as "secondhand tan."

Banning or taxing tanning booths would reduce basal cell carcinomas, but whether the government should take that step is up for debate, said Feldman, who was not involved in the new study.

For his older patients who are diagnosed with skin cancer, he recommends wearing a hat and gives them catalogs of sun-protective clothing.

With young people, it may be a good idea to remind them not to tan indoors, he said.

"For the typical patient who gets diagnosed, though, we don't need to tell them," Feldman said.

SOURCE: bit.ly/12reDen JAMA Dermatology, online July 3, 2013.

  • Some tanners return to the booth after skin cancer

    Some tanners return to the booth after skin cancer
    NEW YORK (Reuters Health) - One in seven people goes back to a tanning bed after being diagnosed with skin cancer, according to a new research letter. Indoor tanning is known to increase a person's risk for cancer. "The situation may be analogous to
  • FDA approves Roche skin cancer drug

    FDA approves Roche skin cancer drug
    n">U.S. health regulators on Monday approved Roche's pill to treat an advanced form of the most common form of skin cancer, known as basal cell carcinoma. The drug, Erivedge, which was co-developed by Curis Inc, was given a green light by the Food
    2012-01-30 ROCHEAPPROVAL
  • Skin cancer more deadly when caught during pregnancy

    Skin cancer more deadly when caught during pregnancy
    n">(Reuters Health) - Melanoma may be even more dangerous when it's diagnosed in women during pregnancy or within a year of giving birth, a U.S. study suggests. Among women under 50 with malignant melanoma, those diagnosed during or soon after pre
  • Common skin cancer drug smoothes wrinkles: study

    Common skin cancer drug smoothes wrinkles: study
    CHICAGO A cream used to treat the early signs of skin cancer may erase wrinkles and leave behind younger-looking skin, U.S. researchers said on Monday. They said Valeant Pharmaceuticals' cream Efudex, which is used to treat actinic keratoses, a preca
    2009-06-16 CANCERSKIN
  • Tanning may up skin cancer risk for palest kids

    Tanning may up skin cancer risk for palest kids
    NEW YORK (Reuters Health) - Very light-skinned children who tan in the sun develop significantly more moles than their peers who stay pale in the sun, new research shows. The number of moles a person has is among the strongest risk factors for develo
    2009-09-22 CANCERTANNING
  • Skin cancer can be inherited: studies

    Skin cancer can be inherited: studies
    NEW YORK (Reuters Health) - Want to reduce your risk of skin cancer? Wear sun screen, of course. But two new studies suggest that choosing your relatives carefully could also be helpful. One found that having an identical twin with melanoma increased
    2009-10-10 CANCERSKIN
  • Studies show how skin cancer evades promising drug

    Studies show how skin cancer evades promising drug
    CHICAGO U.S. researchers have uncovered several ways in which melanoma can outsmart a promising experimental cancer pill called PLX4032, a finding that could lead to new drugs to keep the deadly skin cancer at bay, the teams said on Wednesday. Resear
    2010-11-24 CANCERPILLRELAPSE
  • Positive skin cancer drug data boosts Roche

    Positive skin cancer drug data boosts Roche
    ZURICH Roche's new cancer drug vismodegib could help patients with a potentially fatal skin cancer type, positive mid-stage trial results showed, going some way to lift confidence in the drugmaker after a rough 2010. Roche is struggling to find its f
    2011-03-21 ROCHE
  • FDA approves Roche skin cancer drug Zelboraf

    FDA approves Roche skin cancer drug Zelboraf
    WASHINGTON U.S. drug regulators on Wednesday approved a targeted skin cancer drug from Roche Holding along with its diagnostic test, an advance in personalized health care. The Food and Drug Administration was two months ahead of schedule in approvin
    2011-08-17 ROCHEZELBORAF
  • Should your hairdresser screen you for skin cancer?

    Should your hairdresser screen you for skin cancer?
    NEW YORK (Reuters Health) - Next time you get a haircut, you might end up with something you didn't expect: a referral to a dermatologist. A survey of Texas hair salons out today found more than a third of stylists check at least half of their custom
    2011-10-17 HAIRDRESSER
  • Panel backs skin cancer advice for youths

    Panel backs skin cancer advice for youths
    NEW YORK (Reuters Health) - A government-backed expert panel joined in the fight against skin cancer on Tuesday with a proposal urging doctors to counsel fair-skinned youths about sun protection. "The definition of fair skin is it doesn't tan very we
    2011-11-08 CANCER
  • Tanning beds raise risk of common skin cancer: study

    Tanning beds raise risk of common skin cancer: study
    n">Tanning beds have already been linked to an increased risk of the deadliest type of skin cancer and now new research shows they can also raise the odds of developing the most common form of the disease. Scientists at the Yale School of Public H
    2011-12-13 CANCERTANNINGBEDS
  • Roche gets Swiss approval for skin cancer drug

    Roche gets Swiss approval for skin cancer drug
    ZURICH Swiss drugmaker Roche Holding AG has received Swiss approval for Erivedge, the first medicine for people with advanced forms of basal cell carcinoma, the most common skin cancer. Roche, the world's largest maker of cancer drugs, said about 10,
    2013-06-11 ROCHECARCINOMA
  • Tanning beds must carry skin cancer warning: U.S. FDA

    Tanning beds must carry skin cancer warning: U.S. FDA
    n">The U.S. Food and Drug Administration is strengthening its regulation of tanning beds, which have been shown to increase the risk of skin cancer. The FDA, which is reclassifying sun lamp products from low risk to moderate risk, said on Thursday
    2014-05-29 FDATANNING
  • Roche skin cancer drug meets main goal in combination study

    Roche skin cancer drug meets main goal in combination study
    ZURICH An experimental drug from Roche helped people with an advanced form of skin cancer live longer without their disease worsening when used in combination with another treatment, the Swiss drugmaker said on Monday. Pharmaceutical companies are lo
    2014-07-14 ROCHEDRUGS
  • FDA panel recommends approval for Amgen's skin cancer immunotherapy

    FDA panel recommends approval for Amgen's skin cancer immunotherapy
    n">Amgen Inc's skin cancer immunotherapy showed enough efficacy in the treatment of melanoma to be given marketing approval, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday. The panel voted 22-1 supporting
    2015-04-29 FDAAmgen
  • FDA approves Novartis's advanced skin cancer drug

    FDA approves Novartis's advanced skin cancer drug
    n">The U.S. Food and Drug Administration approved Novartis AG's oral pill to treat the most common form of advanced skin cancer. The drug, Odomzo, carry a boxed warning to alert the risks that it may cause death or severe birth defects in a develo
    2015-07-24 FDANOVARTIS
  • Could mobile devices raise skin cancer risk?

    Could mobile devices raise skin cancer risk?
    n">(Reuters Health) - Devices like tablets, smartphones and laptops can reflect ultraviolet light from the sun and may indirectly increase users' exposure to the cancer-causing wavelengths, according to a new study. "These devices are general
  • Roche skin cancer combination therapy gets EU panel backing

    Roche skin cancer combination therapy gets EU panel backing
    ZURICH Roche is expecting the European Commission this year to issue a final decision on a drug combination to treat advanced skin cancer, based on a drug panel's positive opinion made public on Friday. The European Union's Committee for Medicinal Pr
    2015-09-25 CANCERROCHECOMBO
  • Novartis gets FDA approval for skin cancer drug combination

    Novartis gets FDA approval for skin cancer drug combination
    n">Novartis AG said on Friday it received the U.S. Food and Drug Administration's regular approval for a drug combination to treat an aggressive form of skin cancer. The FDA approved Tafinlar and Mekinist for treatment of metastatic melanoma based
    2015-11-20 FDANOVARTIS

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated